{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-106817","form_type":"8-K","ticker":"TNYA","cik":"0001858848","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.979823+00:00","generated_at":"2026-05-31T04:42:32.351978+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Tenaya Therapeutics adopts 2024 Inducement Plan, reclassifies director to balance board","bullets":["Karah Parschauer reclassified from Class I to Class II director to balance board classes (3 per class).","Board reduced size to 9 directors; Parschauer's compensation unchanged, remains on Audit Committee.","Adopted 2024 Inducement Equity Incentive Plan, reserving 1,200,000 shares for new-hire inducement awards.","Plan intended as material inducement for new employees; no shareholder approval required under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-106817","json":"https://secwatch.observer/filing/0000950170-24-106817.json","markdown":"https://secwatch.observer/filing/0000950170-24-106817.md","text":"https://secwatch.observer/filing/0000950170-24-106817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/0000950170-24-106817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/tnya-20240912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:42:32.351978+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}